Editors: Dulce Elena Casarini, Danielle Yuri Arita, Juliana Almada Colucci, Tatiana Sousa Cunha

New Aspects of the Renin Angiotensin System in Cardiovascular and Renal Diseases

eBook: US $129 Special Offer (PDF + Printed Copy): US $219
Printed Copy: US $155
Library License: US $516
ISBN: 978-1-68108-314-8 (Print)
ISBN: 978-1-68108-313-1 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810831311160101


The renin-angiotensin system (RAS) is a hormonal system that is responsible for regulating plasma sodium ion concentration and arterial blood pressure in the body. The system involves several peptides such as angiotensin I and II as well as angiotensin converting enzyme (ACE) to enable the constriction of arterial blood vessels in the lung. Angiotensin II also stimulates the production of the hormone aldosterone in the kidneys which brings sodium ions into the bloodstream in exchange for potassium ions. Malfunctions of the RAS can lead to hypertension, heart failure, diabetes and renal complications. Thus the biochemical components of this system serve as important targets for therapeutic drugs.

This monograph is a compilation of updated reviews on the RAS. The monograph covers describes the components of the system to explaining its physiological and clinical features in the cardiovascular system and the kidneys. This is followed by sections explaining the biochemistry of the RAS system in cardiovascular and renal disease and the pharmacology of relevant therapeutic drugs. Additional information on the effect of exercise states and methods to quantify angiotensins for molecular diagnosis is also presented in the concluding sections.

Information in the monograph will be of interest to physiologists and endocrinologists involved in medical studies or clinical practice. Readers will be able to understand the RAS with a holistic frame of reference.


Research on the pleiotropic actions and consequences of the renin angiotensin system (RAS) and its many effector components remains fascinating and interesting because new surprises continue to emerge and provide fodder for further analysis and new experimental directions. The older paradigm was so straightforward and simple focusing primarily on the circulating RAS and a single effector peptide, angiotensin II [Ang II]. However, we now know that the system is much more complex exhibiting multiple actions of various active components via different receptors and utilizing various important enzymatic pathways. In this exciting new e-book by Dr. Casarini and her colleagues, a number of important new concepts are presented which further demonstrate the complexity of the RAS system and the many effector components. As pointed out in the first few chapters, evidence obtained during the previous one or two decades has led to an expanded view of the RAS serving paracrine, intracrine, and endocrine functions. Our attention is also directed to the findings that many other angiotensin peptides also exert bioactive roles.

Several of the subsequent chapters then delve into the intricacies of the local tissue RAS activities focusing on the paracrine and intracrine functions of Ang II in the heart and kidneys as well as other angiotensin peptides including Ang 1-7. The more recently discovered components of the tissue RAS, including ACE2 and the prorenin receptor, are also integrated into the overall interactions that occur at the tissue and cellular level and also within the intratubular network in the kidneys. Our attention is then directed to a consideration of the complex enzymatic pathways that are responsible for the generation of the various angiotensin peptides. The roles of tonin, ACE and ACE2 and ACE polymorphisms are examined.

Additional chapters discuss the novel developments related to the ACE2/Mas axis and how it influences formation and action of Ang 1-7, and our evolving concepts regarding the renin-prorenin receptor and their possible roles in regulating the local formation and activities of Ang 1-7 and the prorenin receptor. Completing the book, the remaining chapters deal with RAS related pathophysiology and the roles of immunity and inflammation activated by Ang II, the interactions with the nitric oxide system and catecholamines, and how emotional stress and exercise may alter the activity of the RAS. Finally, a consideration of how the activity of the RAS is modulated in animal models of hypertension and diabetes provides further insights on pathophysiological contributions of the RAS in disease states.

In this e-book, Dr. Casarini and her associates have provided us with an outstanding array of topics which are covered in-depth and will be of tremendous value not only to investigators directly involved in studies of the RAS but also to all colleagues who are interested in obtaining a comprehensive appreciation of the current state of knowledge regarding the regulation and roles of the many components of the “modern” RAS.

L. Gabriel Navar
Department of Physiology
Center of Biomedical Research
Excellence in Hypertension and Renal Biology
Tulane University School of Medicine


.Phytotherapy in the Management of Diabetes and Hypertension.
.Phytotherapy in the Management of Diabetes and Hypertension.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Understanding Obesity: From its Causes to Impact on Life.